Conference Coverage
Latest Content
Jan 31, 2026 | News
Most Patients With MCL in Study of Pirtobrutinib Show Stable or Improved Physical Symptoms, QOL
Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors
Jan 31, 2026
Tildrakizumab Shows Long-Term Psoriasis Control for Hard-to-Treat Areas
Jan 30, 2026
Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM
Jan 30, 2026
Health Equity & Access Weekly Roundup: January 30, 2026
Jan 30, 2026
Advertisement
Shorts
1:15
Strengthening Trial Infrastructure to Broaden Patient Access: Tina Bhatnagar, DO
19 hours ago
by
Maggie L. Shaw(+1 more)
1:03
Restoring the Optic Nerve a Primary Goal in the Future of Glaucoma Treatment: Ariana Levin, MD
3 days ago
by
Julia Bonavitacola(+1 more)
1:40
Glaucoma Seeing Emerging Therapies in Eye Drops, Surgery Modalities: Jullia Rosdahl, MD, PhD
4 days ago
by
Julia Bonavitacola(+1 more)
1:04
Catching Glaucoma Early Relies on Consistent Testing With Eye Doctors: Ariana Levin, MD
5 days ago
by
Julia Bonavitacola(+1 more)
0:39
Closing Data Gaps in Precision Oncology: Tina Bhatnagar, DO
5 days ago
by
Maggie L. Shaw(+1 more)
0:40
Glaucoma Can Be Mitigated Through Screening Those at Highest Risk: Manjool Shah, MD
7 days ago
by
Julia Bonavitacola(+1 more)
0:53
Increased Influenza Hospitalizations Underscore the Need for Stronger Prevention Strategies: Marco del Riccio, MD
7 days ago
by
Brooke McCormick(+1 more)
1:14
Laser, Eye Drops Are First-Line Treatment for Glaucoma: Jullia Rosdahl, MD, PhD
8 days ago
by
Julia Bonavitacola(+1 more)
1:24
Integrated, Age-Specific Care Is Essential for Young Patients With Breast Cancer: Yara Abdou, MD
8 days ago
by
Brooke McCormick(+1 more)
1:15
Glaucoma Known as the "Silent Thief" of Vision: Manjool Shah, MD
9 days ago
by
Julia Bonavitacola(+1 more)
Center on Health Equity & Access
Start seeing what truly shapes access and learn how you can redefine the landscape.
New Year, New Look, Same Brand You Trust
A new look for AJMC, with the same trusted research and insights.
Podcasts
Center on Health Equity & Access
Continuing Medical Education
Advertisement
All News
Advertisement
Empathy, knowledge, and attitudes in care for patients with myasthenia gravis were improved when using a patient-centric immersive virtual reality intervention.
Discover how innovations in biology and engineering are transforming dermatology, featuring breakthroughs in laser therapies and precision medicine.
New research highlights the effectiveness of targeted therapies for metabolic dysfunction–associated steatohepatitis (MASH), guiding treatment decisions and trial designs.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Standard double reading did not perform as well as artificial intelligence for looking at catching cancer and reduced the rate of breast cancer diagnosis by 12%.
Vivian Shi, MD, discusses the evolving strategies for managing hidradenitis suppurativa, including biologics and combination therapies, at Maui Derm 2026.
Better integration of pharma and medical technology is necessary to enhance patient outcomes and drive value-based care.
Disparities in access to allo-HCT for AML persist, highlighting the need for targeted interventions to ensure equitable treatment for all patients.
This new study reveals venetoclax and rituximab effectively treat chronic lymphocytic leukemia, showing high response rates and prolonged progression-free survival.
Advertisement
Advertisement
Trending on AJMC
1
Virtual Reality Intervention Increased Empathy for Patients With MG
2
ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care
3
Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors
4
Ambient AI Tool Adoption in US Hospitals and Associated Factors
5
